The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase.

A significant number of patients who belonged to serological IT phase were not in histologic IT phase. Patients over 35 years and those with high AST, low albumin and low HBV DNA levels were more likely to experience poor long-term clinical outcomes. Therefore, additional histologic assessment should be considered.